BioCentury
ARTICLE | Company News

MGI deal

May 1, 1995 7:00 AM UTC

MGI Pharma Inc. (MOGN) MOGN granted Dainippon Pharmaceutical Co. Ltd. (Osaka) an exclusive six-month option to acquire a license for the right to develop and market acylfulvenes in Japan. Dainippon p...